Celyad Oncology SA
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Celyad Oncology SA's balance sheet done over the years? Its assets were worth $16,282,000 last year, which is less than in the previous period. 61% of Celyad Oncology SA’s total assets is currently financed by debt. Its liabilities reached the amount of $9,978,000, which means an decrease by -69% compared compared to last year.
Debt to Assets
| 2014 | 43976000 | 17.29M | 39.32% |
|---|---|---|---|
| 2015 | 159525000 | 64.68M | 40.55% |
| 2016 | 138806000 | 64.55M | 46.51% |
| 2017 | 77626000 | 46.72M | 60.19% |
| 2018 | 94299000 | 55.34M | 58.69% |
| 2019 | 89836000 | 60.84M | 67.73% |
| 2020 | 66084000 | 51.72M | 78.27% |
| 2021 | 79943000 | 52.93M | 66.22% |
| 2022 | 19716000 | 32.03M | 162.46% |
| 2023 | 16282000 | 9.97M | 61.28% |
0QFK.L Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 7.00M | 12.44M | 30.01M | 17.23M | 39.33M | 40.54M | 23.25M | 48.35M | 100.17M | 27.63M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 9.19M | 10.65M | 34.23M | 7.33M | 2.67M |
Net receivables | 380K | 1.25M | 2.34M | 908K | 2.70M | 1.26M | 81K | 859K | 62K | 31K |
Inventory | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 642K | 199K | 0 |
Other current assets | 3.73M | 1.12M | 1.93M | 1.56M | 796K | 684K | 2.40M | 1.27M | 544K | 2.6M |
Total current assets | 11.12M | 14.82M | 34.29M | 19.70M | 42.83M | 51.69M | 36.39M | 85.36M | 109.41M | 32.93M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.83M | 309K | 3.24M | 4.11M | 5.06M | 3.01M | 3.29M | 3.56M | 1.13M | 598K |
Goodwill | 342K | 0 | 883K | 883K | 883K | 883K | 914K | 1.04M | 1.00M | 0 |
Intangible assets | 48K | 864K | 36.16M | 36.17M | 36.19M | 36.16M | 36.50M | 49.56M | 48.78M | 9.35M |
Long term investments | 0 | 0 | 2.20M | 5.79M | 5.48M | 3.21M | 273K | 311K | 181K | 68K |
Other non-current assets | 2.94M | 3.71M | 4.02M | 293K | 257K | 215K | 247K | -1.04M | -1.00M | 1.02M |
Total non-current assets | 5.16M | 4.89M | 45.65M | 46.37M | 47M | 42.60M | 41.23M | 53.44M | 50.10M | 11.04M |
Total assets | 16.28M | 19.71M | 79.94M | 66.08M | 89.83M | 94.29M | 77.62M | 138.80M | 159.52M | 43.97M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 509K | 437K | 750K | 859K | 346K | 276K | 226K | 1.10M | 0 | 0 |
Short term debt | 156K | 137K | 902K | 1.11M | 1.35M | 765K | 636K | 561K | 248K | 134K |
Total current liabilities | 2.93M | 10.42M | 13.82M | 11.83M | 11.92M | 9.64M | 7.94M | 11.27M | 11.49M | 6.05M |
| Non-current liabilities: | ||||||||||
Long term debt | 902K | 16.63M | 16.63M | 16.63M | 16.66M | 16.86M | 17.43M | 17.16M | 17.05M | 279K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 6.14M | 271K | 14.89M | 16.51M | 25.15M | 25.31M | 21.33M | 36.11M | 36.13M | 10.96M |
Total non-current liabilities | 7.04M | 21.60M | 39.10M | 39.88M | 48.92M | 45.69M | 38.77M | 53.27M | 53.19M | 11.23M |
Total liabilities | 9.97M | 32.03M | 52.93M | 51.72M | 60.84M | 55.34M | 46.72M | 64.55M | 64.68M | 17.29M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |